Brett D. Anderson

Brett practices principally in the areas of:

• Corporate governance.
• Strategic corporate transactions.
• Mergers and acquisitions.
• Securities regulation and disclosure.
• Corporate finance.
• Executive compensation.
• Compliance and investigations.

Brett represents publicly-held companies in all matters of corporate governance and strategic corporate transactions including mergers, acquisitions, dispositions, tender offers, go-private transactions, activism defense, poison pills, accelerated share repurchases, and Rule 10b5-1 trading plans.

• Representation of a global distributor of health products and services in the $715 million sale of its medical supply business to a private equity firm; its $1.1 billion acquisition of a leading animal health distribution company.
• Representation of a premium coffee company in its negotiation of a merger agreement and its response to a tender offer, a transaction valued at $340 million.
• Representation of a casual dining restaurant group since its IPO, including PIPE transactions, preferred stock financings, a debt restructuring, sale of control to a private equity investor and acquisitions of assets.
• Representation of an NYSE listed bottling company, including $1.4 billion of registered debt issuances, 10b5-1 repurchase plans, adoption of a majority voting policy and a $7.8 billion merger and go-private transaction.
• Representation of a publicly-held thrift holding company in its response to a proxy contest by one of its institutional shareholders.
• Representation of a marketing technologies company in its IPO, follow-on offering and registered direct offerings.
• Representation of a media entertainment licensing company in its go-private transaction.
• Representation of a medical device company since its IPO, including PIPE transactions, a debt conversion, other equity financings, a senior secured debt issuance and follow-on offering.
• Representation of a microbrewery since its IPO in its public disclosures, SEC filings and go-dark transaction.
• Representation of a same-day, time-critical transportation and distribution/logistics services company in its preferred stock and secured note financing transactions.
• Representation of an airline holding company in its dissolution, plan of liquidation and distributions to shareholders.
• Representation of companies seeking no-action relief from the SEC in connection with various shareholder proposals and obtaining confidential treatment for contractual provisions the disclosure of which would cause competitive harm.

• Contributor, M&A Insights for MPR Story, Nov. 6, 2014